KDNY

KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook

By Samuel O'Brient, InvestorPlace Reporter
Chinook Therapeutics is about to be acquired by Novartis. News of this deal hasn't stopped Muddy Waters from betting against KDNY stock.

Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?

By William White, InvestorPlace Writer
Chinook Therapeutics (KDNY) stock is rocketing higher on Monday after the company announced it's being acquired by Novartis AG (NVS).

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

7 Cheap Biotech Stocks to Buy Now

By Shanthi Rexaline
These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector.